In-Depth Cooperation:Sino-German Collaboration for Establishing International Departments

2020-04-13 15:06:35 Guangzhou Gloryren Medical Technology Co., Ltd 285

Recently, Newsweek published the WORLD’S BEST HOSPITALS 2020 Ranking which is in the second collaboration with Statista, a renowned German online portal for statistics.


The rankings are based on recommendations from medical professionals, results from patient surveys and key medical performance indicators and listed the best hospitals in 20 countries (and one city-state): United States, Canada, Germany, France, United Kingdom, Italy, Spain, Switzerland, Netherlands, Sweden, Denmark, Norway, Finland, Israel, South Korea, Japan, Singapore, India, Thailand, Australia and Brazil to achieve the ultimate outcome among 1,500 hospitals.

World's Best Hospitals 2020 – Top 10 Global

1    Mayo Clinic - Rochester   USA

2    Cleveland Clinic    USA

3    Massachusetts General Hospital  USA

4    Toronto General (University Health Network)     Canada

5    Charité - Universitätsmedizin Berlin  Germany

6    The Johns Hopkins Hospital   USA

7    Universitätsspital Zürich   Switzerland

8    Singapore General Hospital (SGH)     Singapore

9    Sheba Medical Center     Israe

10  Karolinska Universitetssjukhuset  Sweden



Best Hospitals – Top 10 in Germany (Among 148 Listed Hospitals)

1    Charité - Universitätsmedizin Berlin Berlin

2    Universitätsklinikum Heidelberg Heidelberg

3    Universitätsklinikum Hamburg-Eppendorf Hamburg

4    Klinikum der Universität München Munich

5    Medizinische Hochschule Hannover Hanover

6    Klinikum rechts der Isar der Technischen Universität München Munich

7    Universitätsklinikum Köln Cologne

8    Universitätsklinikum Freiburg Freiburg

9    Universitätsklinikum Regensburg Regensburg

10  Universitätsklinikum Carl Gustav Carus Dresden



Gloryren is glad to invite the specialists from Charité - Universitätsmedizin Berlin in Top 10 of World's Best Hospitals and Universitätsklinikum Heidelberg, Klinikum der Universität München, Universitätsmedizin Göttingen, Universitätsklinikum Bonn in Best Hospitals – in Germany to help with establishing international departments for Grade Ⅲ A hospitals in China.


Let’s find out who are these specialists introduced by Gloryren for Grade A hospitals in China.



Prof. Dr. med. Joerg-Christian Tonn

Chairman and Professor of Neurosurgery at the Department of Neurosurgery, Ludwig-Maximilians-University Munich, Germany

Research Activities:

l  Clinical and experimental neurooncology

l  Metabolic imaging in neurosurgery

l  Skull base surgery


Work Experience:

l  Since 2001  Chairman and Professor of Neurosurgery at the Department of Neurosurgery, Ludwig-Maximilians-University Munich, Germany

l  2000   Appointment as C4 Professor of Neurosurgery at University of Hamburg and Ludwig-Maximilians-University Munich, Germany

l  1997 Appointment as Professor of Neurosurgery at the Julius-MaximilianUniversity Würzburg, Germany

l  1996  Appointment as Vice-Director of Department, Department of Neurosurgery, University Hospital Würzburg, Germany

l  1991    Attending neurosurgeon, University-Hospital of Würzburg, Germany



l  DGNC (German Association of Neurosurgery)

l  GANS (German Academy of Neurological Surgeons)

l  EANO (European Association of Neuro Oncology), founding member

l  (NCAFW)German neurosurgical educational academy

l  EANS ( European Association of Neurosurgical Societies) 

Internal Medicine——Oncology


Prof. Dr. med. Dr. rer. nat. Michael von Bergwelt

Director of Medical Clinic and Polyclinic -- Oncology and Hematology, Hospital of Ludwig-Maximilians-University, Munich

Work Experience:

Since Dec. 2017: Professor of Medicine & Chair, Department of Internal Medicine III, Ludwig- Maximilians-University, Munich

2009-2017: Senior Attending Physician (HR, Communication, Finances)

2008: Director, Cologne Interventional Immunology, Co-Director BMT Program & Medical Critical Care Program

2007: Attending Physician, Department of Internal Medicine III, Ludwig- Maximilians-University, Munich



l  Since Jan. 2018: German Cancer Consortium (DKTK), partner site Munich

l  2003-2009: Head, Max-Eder Junior Research Group, German Cancer Aid


Awards, distinctions and professional activities

2015: Best Abstract Award DGHO (co-author)
2010: Travel Award, American Society for Blood and Marrow Transplantation
2010: Basic Science Award (Abstract O84, last author), European Society for Blood and Marrow Transplantation
2002: Fellow, German José Carreras-Leukemia Foundation
2001: Fellow, Lymphoma Research Foundation of America
1999: 'Travel Award' of the American Society of Hematology
1999: Scientific Award EMSA / University of Prague
1997: Mildred-Scheel Fellow, German Cancer Aid

Selected publications:

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 2002; 99: 3319-25.
Dendritic cells and CD40-activated B cells: New avenues to cancer immunotherapy. Trends Immunol, 2004; 25: 659-664.
CD25 and indoleamine 2,3-dioxygenase are upregulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo. Blood 2006, 108(1):228-37.
Brentuximabvedotin combined with donor lymphocyte infusions for early relapse of hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity and sustained clinical remission. J Clin Oncol. 2013 Feb 10;31(5):e59-63. doi: 10.1200/JCO.2012.43.6832.

Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation resulting in the acquisition of tolerogenic features and a reduced capacity to induce T cell immunity.  J Immunol. 2014 Nov 15;193(10):5294-305.

Emergency Medicine


Prof. Dr. med. Sabine Blaschke

Head of Interdisciplinary Emergency Care Department(INA), University Medical Center Goettingen

Clinical Focus:

l  Emergency medicine

l  Internal medicine

l  Nephrology

l  Intensive care medicine

Scientific Focus:

l  Standard operating procedures in emergency medicine

l  Clinical studies on biomarkers, process evaluation and quality management in

emergency medicine

l  Information technology and artificial intelligence in emergency medicine

Work Experience:

l  2016  Board Certification Certified Emergency Department Executive

l  Since 2012  Head of Interdisciplinary Emergency Care Department , University Medical Center Göttingen

l  2006-2012  Senior Consultant,  Interdisciplinary Emergency Care Department , University Medical Center Göttingen


l  German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI)

l  German Society for Interdisciplinary Emergency and Acute Medicine (DGINA)

l  European Society For Emergency Medicine (EUSEM)

Project Coordinator:

l  Intelligent assistance services and personalised learning environments for knowledge and action support in the interdisciplinary emergency room (A.L.I.N.A)

l  Optimization of emergency care through structured initial assessment using intelligent assistance services (O.P.T.I.N.O.F.A)


l  SOP Handbuch Interdisziplinäre Notaufnahme



Prof. Dr. med. Simone Scheithauer

Head of the Institute for Infection Control & Infectious Diseases, University Medical Center Goettingen

Scientific career:

•  Since 2018 W3 professorship for Infection Control and Infectious Diseases, UMG

•  Since 2014 Division Head of Infection Control & Infectious Diseases, UMG

•  2012 habilitation "Standardization in Infection Prevention and Infectiology as a Quality Assurance Instrument", University Hospital Aachen (UKA) / RWTH

•  2010 Consultant for Infection Control & Environmental Medicine

•  2007 Consultant for Microbiology, Virology & Epidemiology of Infectious Diseases



•  Conference president - annual meeting DGHM2019, Göttingen

•  Speaker DGHM "Section Antibiotic Resistance and Infection Control"

•  Vice-congress president - 14th Congress for Infectious Diseases and Tropical Medicine, Cologne 2018 (KIT)

•  Member of the "Commission for Hospital Hygiene and Infection Prevention" (KRINKO)


Editorial board

•  Requirement for hospital and practice hygiene

•  Up2date hospital hygiene

Research funding / grants (qwn share of the funding in €) :

•  ProfProg2 (female professor program), PI with equal opportunities office; BMBF / UMG / MWK Lower Saxony, October 1, 2015 - September 30, 2020, € 375,000

•  MRE-TRAVIK (multi-resistant pathogens: transmission and kinship analysis for the identification of evidence-based control strategies) Nds.Prof. (VW in advance), PI; MWK Lower Saxony / UMG, 01.10.2017-30.09.2020, 270,000 €

•  INSIST (impact of neonatology screening on infection prediction / reduction of transmissions), PI; BMG innovation fund, 01.09.2017-31.08.2020, 400,000 €

•  AntiRedMen (Randomized controlled trial: antiseptics to reduce nosocomial meningiventriculitis), PI; Estate Ms. Lore Grun UMG, May 1, 2019 - April 31, 2022, € 350,000

Gynecology and Obstetrics


Prof. Dr. med. Christof Reinhard Sohn

Medical Director (Gynecology and Obstetrics) Head of Center (Center for Gynecological Cancer) Heidelberg University Women's Clinic

Medical Career:

• November 2004: Managing Director of Heidelberg University Women's Clinic

• 2002: Managing Director of the Center for Gynecology at the MHH

• 1993: Appointed senior physician at Heidelberg University Women's Clinic

• 1991-1997: Research Associate at Heidelberg University Women's Clinic (Prof. Dr. Dr.hc G. Bastert)

• 1991-1997: Resident Physician Department Gynecology / Obstetrics Albstadt District Hospital (Prof. Dr. G. Geier)


Own Developments:

• 3D Ultrasoundtechnology

• Telemedical project in Cooperation with Telecom

• Development of Meniscus-Sonography (1985) 



• Member of the German Association of Unltasound in Medicine (DEGUM)

• Member of the German Association of Obstetrics and Gynecology (DGGG)

• Member of the German Association of Perinatal Medicine

• Member of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)

• Member of the Academic Foundation for Medical Education, Switzerland

Breast Surgery


Prof. Dr. med. Andree Faridi

Professor and Director, Department of Senology/Breast Center, University Hospital Bonn

Work Experience:

• 2018: Professor and Director, Department of Senology/Breast Center, University Hospital Bonn

• 2011-2018: Professor and Head, Vivantes Breast Center

• 2007–2011:Professor and Head, Department of Gynecology and Beast Unit, Asklepios Hosptial Barmbek, Academic Teaching Hospital, University of Hamburg

• 2004: Head, Department of Obstetrics and Gynecology, City Hospital ColognePorz, Academic Teaching Hospital, University of Cologne (Specialist in Utrasound Examination of Breast)

• 2003: Head, Department of Senology and Breast Surgery, Technical University of Aachen, Germany



• FOCUS List of TOP DOCTORS in “Breast Cancer”



• Deputy Chairman, German Society of Senology of DGS

• Member, Board, German Society of Gynecology and Obstetrics

• Member, German Cancer Society

• Faculty Member, Society of Reconstructive, Plastic and Aesthetic Surgery (AWOgyn) of the German Society of Gynecology and Obstetrics

• Member of Panel, Oncoplastic Breast Consortium (OPBC)

• Faculty Member, European Academy of Senology (EAoS)

• Faculty Member, Turkish Academy of Senology (SENATURK)



Prof. Dr. med. Markus Hohenfellner

Director of Department of Urology, University Hospital of Heidelberg

Clinical Focus:

• Minimally invasive urology

• Retroperitoneal surgery

• Urologic oncology

• Reconstructive urology

• Pediatric urology


Clinical and Scientific Fields of Competence:

• Minimal Invasive Surgery

including endoscopic, laparoscopic and robotic surgery of the adrenal, kidney, ureter, bladder and prostate for benign and malignant disease.

• Retroperitoneal Surgery

including endoscopic and open stone surgery; nephron-sparing tumor resection; laparoscopic tumor nephrectomy; tumor nephrectomy with resection of caval thrombi; thoracoabdominal approach for very large kidney or adrenal tumors and local recurrence of kidney tumors; renal transplantation (cadaveric and living donor)

• Radical Tumor Surgery in the Small Pelvis

including robotic, retropubic and perineal radical prostatectomy, radical and ultraradical cystectomy/anterior exenteration; anterior exenteration for gynecological tumors in cooperation with Gynecological Surgeons; complete exenteration for intestinal tumors in cooperation with General Surgery.

• Reconstruction of the Lower Urinary Tract

• Pediatric Urology

Brief Introduction:

Markus Hohenfellner is Professor of Urology and Director of the Department of Urology of the University Hospital Heidelberg.

The Scientific and clinical focus of Markus Hohenfellner is urologic oncology and tumor surgery, minimally invasive urology including robotics and continent reconstruction of the lower urinary tract. The Department of Urology Heidelberg covers the entire spectrum of modern urology including prevention, early detection, ultraradical tumor surgery, minimally invasive and robotic-assisted surgery (Da Vinci) lower urinary tract dysfunction, pediatric urology, stone therapy and andrology.

In the translational perspective, the Department of Urology Heidelberg has implemented a section of Molecular Urooncology, directed by Prof. Stefan Duensing. It is renown research institution on its own as well as critical gateway to relevant basic science institutions and working groups.

Hohenfellner is a member of several national and international urological societies and author or co-author of numerous scientific publications and book chapters, as well as publisher of two urological science books. He has been awarded scientific prizes of various national and international urological societies, including the European Thesis Award - the prize for the best habilitation thesis of the European Association of Urology - and Maximilian Nitze price - the highest scientific prize of the German Society of Urology.

In 2015 he introduced "Semi-Live" as a new format to communicate surgical science.

Markus Hohenfellner is active volunteer in various medical societies such as the German Continence Society and the German Cancer Aid Foundation. He is governs the European Foundation for Urology (EFU), which e.g. supports tumor research and training of doctors in emerging countries.


Work Experience:

• Since 2003:Chairman, Department of Urology, University Hospital of Heidelberg

• 1997-2003:Senior Consultant, Urological Clinic, the University of Mainz

• 1988-1997:Senior Physician, Department of Urology, University Hospital of Wuppertal



• FOCUS TOP DOCTORS LIST of Urological tumors

• Werner Staehler Prize 2008, Southwest German Society for Urology, Heilbronn

• EAU Thesis Award, European Association of Urology, syMonte Carlo

• Maximilian Nitze Prize, German Society for Urology, Wiesbaden

• Jack Lapides Essay Contest (Grand Prize Award), American Urological Association, Washington

• Miley B. Wesson Resident Essay Contest, Western Section, American Urological Association, Vancouver



• German Continence Society

• European Foundation for Urology (EFU)

• American Urological Association

• European Association of Urology



• Journal of Urology

• Urology

• European Urology

• Neurourology and Urodynamics



Prof. Dr. med. Gerd-Rüdiger Burmester

Director of Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin


Gerd R. Burmester, MD is Professor of Medicine in the Department of Rheumatology and Clinical Immunology at the Charité University Hospital, Free University and Humboldt University of Berlin, Germany. Professor Burmester earned his medical degree from Hannover Medical School and completed a residency at the Medical School of the University of Erlangen-Nuremberg. He was awarded a postdoctoral fellowship at Rockefeller University in New York, and was a visiting scholar at the Hospital for Joint Diseases, Mount Sinai School of Medicine, New York.

Professor Burmester is the recipient of numerous awards, including the Jan van Breemen Medal of the Dutch Society of Rheumatology. He serves on several editorial boards, including the Journal of Rheumatology and Clinical Rheumatology, and he is the Associate Editor of Annals of the Rheumatic Diseases, official journal of EULAR. The author himself of more than 430 original and review articles.


Research interests:

Professor Burmester’s research interests include rheumatoid arthritis, Lyme borreliosis, immunotherapy, cellular activation mechanisms in inflammatory joint diseases, and tissue engineering.


• Since 2005:Director of the Center of Internal Medicine and Dermatology, Charité University Hospital

• 1995-1997:Charité University Hospital, Humboldt-University of Berlin, Additional Appointment as Vice Dean

• Since 1993:Charité University Hospital, Humboldt-University of Berlin, Germany Full Professor of Medicine

• 1990:University of Erlangen-Nuremberg, Professor of Rheumatology and Clinical Immunology



• 1998:Jan van Breemen Medal, Dutch Society for Rheumatology

• 1992:Bruno-Schuler-Award, German Society of Rheumatology



• Since 2017:President of the Board of Trustees of the FOREUM Foundation for Research in Rheumatology

• 2015-2017:President of EULAR

• 2011-2013:Treasurer of EULAR

• 2003-2004:2nd Vice President of the German Society of Rheumatology

• Since 2002:Chairman, EULAR Standing Committee of Investigative Rheumatology and Member of the Executive Committee of the European League against Rheumatism

• 2001-2002:President of the German Society of Rheumatology


Editorial board:


• Journal of Rheumatology

• Journal: Clinical Rheumatology

• Clinical and Experimental Rheumatology

• Zeitschrift für Rheumatologie

• Arthritis Research and Therapy

• Current Opinion in Rheumatology

• Autoimmunity Reviews

• Nature Clinical Practice Rheumatology

Gloryren has reached strategic cooperation with a number of well-known European university hospitals and international hospital groups, focusing on customized international medical service for Grade III-A hospitals in China and helping them with establishing international departments. The vision of Gloryren is to be the disseminator of international diagnosis and treatment standards in China.


HOTLINE: 020-8928-7873 Hospital-centered and detail-oriented.